Arrowstreet Capital Limited Partnership Has $2.46 Million Stock Position in Waters Co. (NYSE:WAT)

Arrowstreet Capital Limited Partnership reduced its position in shares of Waters Co. (NYSE:WAT - Free Report) by 30.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,619 shares of the medical instruments supplier's stock after selling 2,950 shares during the period. Arrowstreet Capital Limited Partnership's holdings in Waters were worth $2,456,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Benjamin Edwards Inc. bought a new stake in shares of Waters in the 3rd quarter worth approximately $256,000. Morse Asset Management Inc acquired a new position in Waters in the third quarter worth approximately $104,000. Stifel Financial Corp increased its holdings in shares of Waters by 3.3% in the third quarter. Stifel Financial Corp now owns 22,695 shares of the medical instruments supplier's stock valued at $8,168,000 after buying an additional 720 shares in the last quarter. National Bank of Canada FI lifted its position in shares of Waters by 44.5% during the 3rd quarter. National Bank of Canada FI now owns 24,247 shares of the medical instruments supplier's stock valued at $8,726,000 after acquiring an additional 7,472 shares during the last quarter. Finally, MML Investors Services LLC boosted its stake in shares of Waters by 8.8% during the 3rd quarter. MML Investors Services LLC now owns 10,297 shares of the medical instruments supplier's stock worth $3,706,000 after acquiring an additional 837 shares in the last quarter. 94.01% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently commented on WAT shares. StockNews.com downgraded Waters from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. UBS Group raised their target price on shares of Waters from $405.00 to $410.00 and gave the stock a "neutral" rating in a report on Thursday, February 13th. KeyCorp upgraded shares of Waters from a "sector weight" rating to an "overweight" rating and set a $460.00 price target on the stock in a report on Monday, March 31st. Wells Fargo & Company lifted their price objective on shares of Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Finally, Baird R W raised shares of Waters from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, March 26th. Ten investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $397.25.

Remove Ads

Waters Stock Down 1.8 %

Shares of WAT stock traded down $5.90 on Tuesday, hitting $327.87. The company's stock had a trading volume of 84,731 shares, compared to its average volume of 474,441. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.94 and a quick ratio of 0.65. The stock has a market capitalization of $19.48 billion, a price-to-earnings ratio of 30.63, a P/E/G ratio of 3.79 and a beta of 1.04. Waters Co. has a fifty-two week low of $279.24 and a fifty-two week high of $423.56. The firm's fifty day moving average price is $367.21 and its 200-day moving average price is $372.32.

Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 earnings per share for the quarter, beating analysts' consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. Research analysts anticipate that Waters Co. will post 12.86 EPS for the current year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.